Focused ultrasound ablation goes after brain tumors

Article

High-intensity focused ultrasound ablation has been tried successfully in soft-tissue tumors in the breast, prostate, kidneys, and liver. The next frontier is the brain.

High-intensity focused ultrasound ablation has been tried successfully in soft-tissue tumors in the breast, prostate, kidneys, and liver. The next frontier is the brain.

The researchers at Iowa State University have developed a computational model to assess the technique through heterogeneous tissue. A $350,000 grant from the Roy J. Carver Charitable Trust will move the investigators to the next phase: testing the application in humans.

"We need to predict what the ultrasound beam will do when it goes through so many layers of tissue. You want to cook only the tumor and not the surrounding cells," said principal investigator Viren Amin, Ph.D.

Researchers also want to define protocols for specific tumor types and intend to use MR and ultrasound imaging to plan for focused ultrasound treatments.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.